LUKANG PHARMACEUTICAL

STRIVING TO DEVELOP FOR 50 YEARS CARING FOR HUMAN HEALTH
NEWS CENTER
LATEST NEWS
Date:2018-03-27
Lukang Pharma's New Product Research and Development Expert Demonstration Meeting was Crowned with Complete Success


In order to improve the research and development capability on the company's new products, strengthen the scientific and accuracy of the new product research and development projects, track the development trends and directions of innovative drugs and generic drugs at home and abroad, and grasp the direction of the national industry policy, recently, Lukang Pharma held the company's new product research and development experts demonstration meeting.

The company invited five well-known experts to attend the meeting, including Professor Zhao Yusheng, Director of Cardiovascular Medicine, Chinese PLA General Hospital, Professor Sun Junzhong, Director of Oncology Department of the first affiliated Hospital of Chinese PLA General Hospital, Professor Guo Ruichen, Director of Pharmacology Institute, Qilu Hospital of Shandong University, Professor Zhang Lanying, President of Shandong Academy of Pharmaceutical Sciences, and Professor Hu Defu, President of Shandong Food and Drug Research Institute.

After the technical report on the new product development of the company, the participating experts commented on the company’s new product research and development. After questioning and exchanging opinions, they all agreed that product series and varieties selection of the 25 generic drugs and 4 Class I innovative drugs involved in the meeting are reasonable and feasible, and suggest that our company carry out the research and development of improved new drugs, increase investment in research and development of new products, combine production, study and research, and increase the efficiency of research and development.

SHARE WITH OTHERS